重新住院预测间歇性肺部疾病急性恶化后的预后不好
Johanna Salonen1,2, Sanna Jansa3, Hannu Vähänikkilä4
1Research Unit of Biomedicine and Internal Medicine, University of Oulu, Oulun Yliopisto, P.O. Box 8000, 90014, Oulu, Finland. Johanna.salonen@oulu.fi.
BMC pulmonary medicine
|July 1, 2023
概括
间歇性肺病急性恶化 (AE-ILD) 幸存者是一个多样化的群体. 非选择性呼吸系统再住院是这些患者预后不佳的关键预测因素,强调需要仔细监测出院后的情况.
科学领域:
- 肺部病理学 肺部病理学
- 临界护理医学 临界护理医学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 间歇性肺病 (AE-ILD) 的急性恶化带来了显著的死亡风险.
- 对AE-ILD幸存者的预测结果的预测因素仍然不太了解.
- 描述AE-ILD幸存者对于改善患者管理至关重要.
研究的目的:
- 描述那些在间歇性肺病 (AE-ILD) 急性恶化中幸存下来的患者.
- 为了确定AE-ILD幸存者的预后因素.
- 了解AE-ILD幸存者的长期结果.
主要方法:
- 对来自芬兰北部的128名AE-ILD患者的回顾性分析.
- 从95名活着出院的患者的医疗记录中收集的数据.
- 包括住院期间和六个月随访期间的临床数据.
主要成果:
- 异形性肺纤维化 (IPF) 在53名患者中被诊断为异形性肺纤维化;其他ILD在42名患者中.
- 大多数患者 (三分之二) 不需要侵入性或非侵入性通风.
- 在多变量分析中,非选择性呼吸系统再住院是死亡的唯一独立风险因素.
- 肺功能测试显示,六个月的幸存者没有显著下降.
结论:
- AE-ILD幸存者代表了一个临床异质的人群,结果各异.
- 非选择性呼吸系统再住院成为预后不佳的重要标志物.
- 需要进一步的研究来优化AE-ILD幸存者的护理途径.
相关概念视频
Pneumonia IV: Management
367
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
367
Pneumonia I: Introduction
281
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
281
Pneumothorax-II
214
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
214
Pneumonia III: Complications and Assessment
275
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
275
Acute Respiratory Failure-V
166
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
166
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


